Mechanisms of IFNγ regulation of autoimmune myocarditis

Experimental and Molecular Pathology

Volumn 89, Issue 2, 2010, Pages 83-91

  Barin, Jobert G ^a   Talor, Monica V ^a   Baldeviano, G Christian ^b   Kimura, Miho ^a   Rose, Noel R ^a,b   Čiháková, Daniela ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Apoptosis; Autoimmune disease; Caspase 8; Interferon gamma; Myocarditis; Nitric oxide

Indexed keywords

CASPASE; CD4 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; NITRIC OXIDE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; GENOTYPE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYOCARDITIS; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; PHYSIOLOGY;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; INTERFERON-GAMMA; INTERFERON-GAMMA, RECOMBINANT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCARDITIS; SPECIFIC PATHOGEN-FREE ORGANISMS; RECOMBINANT PROTEINS;

MUS;

EID: 77956440510     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.06.005     Document Type: Article

References (44)

1. Afanasyeva M., et al. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 2001, 104:3145-3151.
2. Afanasyeva M., et al. Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knockout mice. Circulation 2004, 110:2910-2917.
3. Afanasyeva M., et al. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc. Natl Acad. Sci. USA 2005, 102:180-185.
4. Alderson M.R., et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995, 181:71-77.
5. Baldeviano, G. C., et al., Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy. Circ Res.
6. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
7. Billiau A., Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev. 2009, 20:97-113.
8. Casciano I., et al. Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE). Cell Death Differ. 2004, 11:131-134.
9. Chang J.H., et al. IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis. Eur. J. Immunol. 2009, 39:1241-1251.
10. Chu C.Q., et al. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000, 192:123-128.
11. Chu C.Q., et al. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann. Rheum. Dis. 2003, 62:983-990.
12. Cihakova D., Rose N.R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 2008, 99:95-114.
13. Cihakova D., et al. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am. J. Pathol. 2008, 172:1195-1208.
14. Eriksson U., et al. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J. Immunol. 2001, 167:5464-5469.
15. Furlan R., et al. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J. Immunol. 2001, 167:1821-1829.
16. Gor D.O., et al. TH1-TH2: a procrustean paradigm. Nat. Immunol. 2003, 4:503-505.
17. Haak S., et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 2009, 119:61-69.
18. Harrington L.E., et al. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr. Opin. Immunol. 2006, 18:349-356.
19. Hill S.L., Rose N.R. The transition from viral to autoimmune myocarditis. Autoimmunity 2001, 34:169-176.
20. Ishiyama S., et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997, 95:489-496.
21. Ivanov I.I., et al. Transcriptional regulation of Th17 cell differentiation. Semin. Immunol. 2007, 19:409-417.
22. Kelchtermans H., et al. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res. Ther. 2005, 7:R402-R415.
23. Kelchtermans H., et al. How interferon-gamma keeps autoimmune diseases in check. Trends Immunol. 2008, 29:479-486.
24. Li J.H., et al. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am. J. Pathol. 2002, 161:1485-1495.
25. Li X., et al. IFN-{gamma} acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol. 2007, 179:939-949.
26. Luger D., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008, 205:799-810.
27. MacMicking J., et al. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
28. Marrack P., Kappler J. Control of T cell viability. Annu. Rev. Immunol. 2004, 22:765-787.
29. Matthys P., et al. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J. Immunol. 1999, 163:3503-3510.
30. Newton K., Strasser A. Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system. Genes Dev. 2003, 17:819-825.
31. Nowak E.C., et al. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 2009, 206:1653-1660.
32. Rangachari M., et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 2006, 203:2009-2019.
33. Refaeli Y., et al. Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 2002, 196:999-1005.
34. Salmena L., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 2003, 17:883-895.
35. Sedgwick J.D., Mason D.W. The mechanism of inhibition of experimental allergic encephalomyelitis in the rat by monoclonal antibody against CD4. J. Neuroimmunol. 1986, 13:217-232.
36. Smith S.C., Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 1991, 147:2141-2147.
37. Sonderegger I., et al. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 2008, 205:2281-2294.
38. Tarrant T.K., et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J. Exp. Med. 1999, 189:219-230.
39. Thome M., Tschopp J. TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1. Trends Immunol. 2003, 24:419-424.
40. Tibbetts M.D., et al. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 2003, 4:404-409.
41. Valaperti A., et al. CD11b+monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J. Immunol. 2008, 180:2686-2695.
42. Veldhoen M., et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
43. Ware C.F., et al. Tumor necrosis factor (TNF) receptor expression in T lymphocytes Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol. 1991, 147:4229-4238.
44. Zheng Y., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.